Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and TIMPs

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 4079-4084

  Sugita, Hideyuki ^a   Osaka, Shunzo ^a   Toriyama, Masato ^a   Osaka, Eiji ^a   Yoshida, Yukihiro ^a   Ryu, Junnosuke ^a   Sano, Makoto ^a   Sugitani, Masahiko ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

A disintegrin and metalloproteinase; Chondrosarcoma; Histological grade; Immunohistochemistry; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIF PROTEIN; A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIF PROTEIN 4; A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIF PROTEIN 5; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG; ADAM PROTEIN; ADAMTS5 PROTEIN, HUMAN; AGGRECANASE 1; AGGRECANASE-1; ISOENZYME; METALLOPROTEINASE; PROCOLLAGEN N PROTEINASE;

ARTICLE; CANCER GRADING; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; BIOSYNTHESIS; BONE TUMOR; ENZYMOLOGY; PATHOLOGY;

ADAM PROTEINS; BONE NEOPLASMS; CHONDROSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; PROCOLLAGEN N-ENDOPEPTIDASE; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 14944365686     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sato H and Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993.
2. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994.
3. Flannery CR, Little CB and Hughes CE: Expression of ADAMTS homologues in articular cartilage. Biochem Biophys Res Commun 260: 318-322, 1999.
4. Arner EC, Pratta MA and Trzaskos JM: Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 274: 6594-6601, 1999.
5. Hashimoto G, Aoki T, Nakamura H, Tanzawa K and Okada Y: Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitor of metalloproteinases (TIMPs 1, 2, 3 and 4). FEBS Lett 494: 192-195, 2001.
6. Kashiwagi M, Tortorella M, Nagase H and Brew K: TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biolog Chem 276: 12501-12504, 2001.
7. Dorfman HD and Czerniak B: Bone cancers. Cancer Suppl 75: 203-210, 1995.
8. O'Neal LW and Ackerman LV: Chondrosarcoma of bone. Cancer 5: 551-577, 1952.
9. Soderstrom M, Aro HT, Ahonen M, Johansson N, Aho A, Ekfors T, Bohling T, Kahari VM and Vuorio E: Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS 109: 305-315, 2001.
10. Toriyama M, Rosenberg AE, Mankin HJ, Fondren T, Tredwell BT and Towle CA: Matrix metalloproteinase digestion of aggrecan in human cartilage tumours. Eur J Cancer 34: 1969-1973, 1998.
11. Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA and Scully SP: Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 80: 11-17, 1998.
12. Liotta LA: Tumor invasion and metastases-role of the extracellular matrix. Cancer Res 46: 1-7, 1986.
13. Hart IR and Saini A: Biology of tumor metastasis. Lancet 339: 1453-1457, 1992.
14. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG: Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. AJP 136: 585-592, 1990.
15. McDonnel S, Navre M, Coffey RJ Jr and Matrisian LM: Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcin 4: 527-533, 1991.
16. Chubinskaya S, Huch RS, Qureshi A, Kuettner KE, Block JA and Cole AA: Matrix metalloproteinase, TIMP and cytokine expression by human chondrosarcomas. ORS 42: 549, 1996.
17. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Solomon K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Murphy K, Hillman MC Jr, Hollis GF, Newton RC, Magolda RL, Trzaskos JM and Arner EC: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284: 1664-1666, 1999.
18. Tortorella MD, Malfait AM, Deccico C and Arner E: The role of ADAMTS-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) in a model of cartilage degradation. OARS 9: 539-552, 2001.
19. Okada Y, Shinmei M, Tanaka O, Kaka K, Kimura A, Nakanishi I, Bayliss MY, Iwata K and Nagase H: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66: 680-690, 1992.
20. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS and Woessner JF Jr: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoartritic cartilage. J Clin Invest 84: 678-685, 1989.
21. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K and Okada Y: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59: 455-461, 2000.
22. Hembry RM, Bagga MR, Reynolds JJ and Hamblen DL: Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54: 25-32, 1995.